Media Releases

Category

Monday,  23 March 2020: “As part of World TB Day on 24 March, we want to send a strong message that TB is not a death sentence. However, it is a very serious disease if left untreated. In addition, those with TB who are not on treatment will be at higher risk of worse outcomes...
Read More
Monday 2 December 2019: As the world focused on World Aids Day yesterday, the Clinical HIV Research Unit (CHRU) is calling on communities in Johannesburg, Port Elizabeth and Durban to take part in ground breaking clinical trials to help end HIV and associated diseases like tuberculosis (TB) and cervical cancer. “You could become a participant...
Read More
Wednesday 27 March 2019: A ground breaking new programme, BEAT Tuberculosis, was launched today in Port Elizabeth. It is a world first in the fight against Drug Resistant Tuberculosis (DR TB) that is expected to slash treatment time-frames, make taking treatment far easier and minimise devastating side-effects. The emergence of DR TB, particularly Rifampicin Resistant...
Read More
Thursday, 24 May 2018: “South Africa is leading the world’s response to the HIV epidemic with major research in the prevention, treatment and care of people living with HIV/AIDS, TB and AIDS-related cancers, particularly cervical cancer. This is leading to breakthroughs and new treatments,” says Professor Ian Sanne, head of the Clinical HIV Research Unit (CHRU), a...
Read More
Monday, 13 August 2018: “South Africa is leading the world’s response to the HIV epidemic with major research in the prevention, treatment and care of people living with HIV/AIDS, TB and AIDS-related cancers, particularly cervical cancer. This is leading to breakthroughs, new treatments and significantly reducing death and disease,” says Professor Ian Sanne, head of the...
Read More
Tuesday, 22 May 2018: “South Africa is leading the world’s response to the HIV epidemic with major research projects in the prevention, treatment and care of people living with HIV/AIDS and Tuberculosis (TB) leading to breakthroughs and new treatments,” says Professor Ian Sanne, head and principal investigator at the Clinical HIV Research Unit (CHRU), a division of...
Read More